Affiliation:
1. From the First Department of Internal Medicine, Kobe (Japan) University School of Medicine.
Abstract
Abstract Rho
regulates various cell functions, including cell morphology and motility. However, the functional role of
Rho
on the signaling pathway in myocardial cells (MCs) is unknown. In the present study, we attempted to explore the mode of
Rho
action for c-
fos
gene expression in MCs. Expression of the c-
fos
promoter/enhancer linked to the luciferase reporter gene (c-
fos
luciferase) was stimulated by the wild type of
Rho
A and the point-mutated active form of
Rho
A (
Rho
A Val14) but not the biologically inactive effector domain mutant of
Rho
A.
Rho
GDP dissociation inhibitor inhibited the action of
Rho
A on c-
fos
luciferase expression. The deletion analysis revealed that the c-
fos
serum response element (SRE) and the 12-
O
-tetradecanoylphorbol-13-acetate response element (TRE) mainly account for c-
fos
luciferase expression by
Rho
A Val14. The c-
fos
SRE mutant, which contains an intact binding site for the serum response factor but lacks the ternary complex factor binding site, was activated by
Rho
A Val14. The action of
Rho
A Val14 on c-
fos
luciferase expression was not inhibited by downregulation of protein kinase C, protein kinase C inhibitors, or tyrosine kinase inhibitors. These results indicate that activated
Rho
A stimulates c-
fos
gene expression through the c-
fos
SRE and TRE and that the signaling pathway from activated
Rho
A to the c-
fos
promoter/enhancer is independent of these inhibitor-sensitive pathways in MCs.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献